CSIMarket


Abbvie Inc   (ABBV)
Other Ticker:  
 

Abbvie Inc

ABBV's Fundamental analysis








Looking into Abbvie Inc growth rates, revenue grew by 0.7 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1638

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.31 %

Abbvie Inc 's net income grew by 469.29 % in I. Quarter 2024 year on year, above company average,

More on ABBV's Growth


Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 26.59 in trailing twelve-month period.
Company
50.46
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.55.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.63.


More on ABBV's Valuation
 
 Total Debt (Millions $) 74,001
 Dividend TTM ($) 6 $
 Dividend Yield TTM (%) 3.67 %
 Revenue/Employee (TTM) $ 1,088,060
 Net Income/Employee (TTM) $ 120,080
 Receivable Turnover (TTM) 4.73
 Tangible Book Value (Per Share $) -49.41

Abbvie Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 26.59 in trailing twelve-month period.
Company
50.46
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.55.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.63.

Abbvie Inc Price to Book Ratio is at 37.52 lower than Industry Avg. of 78.99. and higher than S&P 500 Avg. of 0.01

More on ABBV's Valuation

  Market Capitalization (Millions $) 301,906
  Shares Outstanding (Millions) 1,773
  Employees 50,000
  Revenues (TTM) (Millions $) 54,403
  Net Income (TTM) (Millions $) 6,004
  Cash Flow (TTM) (Millions $) 11,356
  Capital Exp. (TTM) (Millions $) -795
  Total Debt (Millions $) 74,001
  Dividend TTM ($) 6 $
  Dividend Yield TTM (%) 3.67 %
  Revenue/Employee (TTM) $ 1,088,060
  Net Income/Employee(TTM) $ 120,080
  Receivable Turnover Ratio (TTM) 4.73
  Tangible Book Value (Per Share $) -49.41

  Market Capitalization (Millions $) 301,906
  Shares Outstanding (Millions) 1,773
  Employees 50,000
  Revenues (TTM) (Millions $) 54,403
  Net Income (TTM) (Millions $) 6,004
  Cash Flow (TTM) (Millions $) 11,356
  Capital Exp. (TTM) (Millions $) -795


    ABBV's Profitability Comparisons
Abbvie Inc achieved increase in profitability, decrease in demand. Operating Margin grew in I. Quarter 2024 to 22.73 % from 22.34 % in IV. Quarter.

Abbvie Inc net profit margin of 11.15 % is currently ranking no. 33 in Major Pharmaceutical Preparations industry, ranking no. 74 in Healthcare sector and number 1008 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 0.94
  Total Debt to Equity (MRQ) 9.2
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.39
  Inventory Turnover Ratio (TTM) 5.01



Abbvie Inc achieved increase in profitability, decrease in demand. Operating Margin grew in I. Quarter 2024 to 22.73 % from 22.34 % in IV. Quarter.

Abbvie Inc net profit margin of 11.15 % is currently ranking no. 33 in Major Pharmaceutical Preparations industry, ranking no. 74 in Healthcare sector and number 1008 in S&P 500.

More on ABBV's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com